FDA Approves Darzalex Combo as Frontline Treatment for Myeloma

The combination use of Darzalex with bortezomib, thalidomide, and dexamethasone was approved for transplant-eligible patients with multiple myeloma.

Source: CancerNetwork - September 26, 2019 Category: Cancer & Oncology Authors: Seth Augenstein Source Type: news